Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 62
Filtrer
1.
Expert Rev Vaccines ; 18(2): 133-151, 2019 02.
Article de Anglais | MEDLINE | ID: mdl-30601095

RÉSUMÉ

INTRODUCTION: The challenge to eradicate malaria is an enormous task that will not be achieved by current control measures, thus an efficacious and long-lasting malaria vaccine is required. The licensing of RTS, S/AS01 is a step forward in providing some protection, but a malaria vaccine that protects across multiple transmission seasons is still needed. To achieve this, inducing beneficial immune responses while minimising deleterious non-targeted effects will be essential. AREAS COVERED: This article discusses the current challenges and advances in malaria vaccine development and reviews recent human clinical trials for each stage of infection. Pubmed and ScienceDirect were searched, focusing on cell mediated immunity and how T cell subsets might be targeted in future vaccines using novel adjuvants and emerging vaccine technologies. EXPERT COMMENTARY: Despite decades of research there is no highly effective licensed malaria vaccine. However, there is cause for optimism as new adjuvants and vaccine systems emerge, and our understanding of correlates of protection increases, especially regarding cellular immunity. The new field of heterologous (non-specific) effects of vaccines also highlights the broader consequences of immunization. Importantly, the WHO led Malaria Vaccine Technology Roadmap illustrates that there is a political will among the global health community to make it happen.


Sujet(s)
Immunisation/méthodes , Vaccins contre le paludisme/administration et posologie , Paludisme/prévention et contrôle , Adjuvants immunologiques/administration et posologie , Santé mondiale , Humains , Immunité cellulaire/immunologie , Paludisme/épidémiologie , Paludisme/immunologie , Saisons , Facteurs temps
2.
Clin Obes ; 5(2): 72-8, 2015 Apr.
Article de Anglais | MEDLINE | ID: mdl-25784286

RÉSUMÉ

The objective of this study was to estimate the impact of maternal body mass index (BMI) on maternal morbidity following unscheduled peripartum hysterectomy. A retrospective cohort study of consecutive peripartum hysterectomies at our institution from 1988 through 2012; scheduled hysterectomies were excluded. Medical records were reviewed and maternal, foetal and surgical data collected for each subject. Maternal BMI was categorized by the National Institute of Health classifications for overweight and obese. Statistical analyses included evaluation for trend. A total of 360,774 women delivered at Parkland Hospital during the study period with 665 (1.8 per 1000 deliveries) unscheduled peripartum hysterectomies performed. BMI was available for 635 women. Gestational diabetes, chronic hypertension and pregnancy-related hypertension were significantly higher in all three obesity categories, P = < 0.01. Post-partum complications, such as venous thrombosis and composite surgical morbidity did not differ among BMI groups. Estimated blood loss and units transfused did not differ across the BMI categories, P = 0.42 and P = 0.38, respectively. Increasing BMI was associated with longer surgical times and more wound infections, P = 0.01. These complications should be considered when approaching a peripartum hysterectomy in patients with obesity.


Sujet(s)
Indice de masse corporelle , Hystérectomie/effets indésirables , Obésité/complications , Période de péripartum , Complications de la grossesse , Adulte , Épidémies , Femelle , Humains , Hystérectomie/statistiques et données numériques , Obésité/épidémiologie , Durée opératoire , Placenta previa , Grossesse , Complications de la grossesse/épidémiologie , Études rétrospectives , Infection de plaie opératoire/étiologie , États-Unis/épidémiologie
3.
Epidemiol Infect ; 141(3): 585-90, 2013 Mar.
Article de Anglais | MEDLINE | ID: mdl-22625176

RÉSUMÉ

Throughout December 2010 and January 2011, Queensland experienced widespread flooding due to unusually protracted and heavy rainfalls. In mid-January 2011, four individuals from a small community in Central Queensland were hospitalized with leptospirosis. A further five cases were subsequently identified from around Central Queensland, bringing the total to nine. Microscopic agglutination testing found that serovar Arborea (Leptospira borgpetersenii serovar Arborea) was presumptively responsible for leptospirosis in seven of nine confirmed cases. Serovars Hardjo and Australis were identified in samples from two remaining cases. All cases had exposure to flood water. No single exposure source was identified. This is the first reported outbreak of leptospirosis in Central Queensland and the first report of leptospirosis cases associated with flood water inundation in Queensland. Public health authorities should continue to promote awareness of leptospirosis in flood-affected populations. Healthcare providers must maintain a high level of suspicion for leptospirosis during and after flood events.


Sujet(s)
Épidémies de maladies , Exposition environnementale , Inondations , Leptospira/isolement et purification , Leptospirose/épidémiologie , Leptospirose/microbiologie , Adolescent , Adulte , Humains , Mâle , Adulte d'âge moyen , Queensland/épidémiologie , Jeune adulte
4.
J Genet Couns ; 22(1): 4-15, 2013 Feb.
Article de Anglais | MEDLINE | ID: mdl-23179172

RÉSUMÉ

The BUN and FASTER studies, two prospective multicenter trials in the United States, validated the accuracy and detection rates of first and second trimester screening previously reported abroad. These studies, coupled with the 2007 release of the American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin that endorsed first trimester screening as an alternative to traditional second trimester multiple marker screening, led to an explosion of screening options available to pregnant women. ACOG also recommended that invasive diagnostic testing for chromosome aneuploidy be made available to all women regardless of maternal age. More recently, another option known as Non-invasive Prenatal Testing (NIPT) became available to screen for chromosome aneuploidy. While screening and testing options may be limited due to a variety of factors, healthcare providers need to be aware of the options in their area in order to provide their patients with accurate and reliable information. If not presented clearly, patients may feel overwhelmed at the number of choices available. The following guideline includes recommendations for healthcare providers regarding which screening or diagnostic test should be offered based on availability, insurance coverage, and timing of a patient's entry into prenatal care, as well as a triage assessment so that a general process can be adapted to unique situations.


Sujet(s)
Aneuploïdie , Diagnostic prénatal , Amniocentèse , Humains
5.
Int J Clin Pract ; 66(11): 1042-51, 2012 Nov.
Article de Anglais | MEDLINE | ID: mdl-23067028

RÉSUMÉ

AIMS: This retrospective administrative claims-based study evaluated comparative persistence and adherence to overactive bladder (OAB) medications in US patients with and without diabetes. METHODS: Patients ≥ 18 years who initiated OAB medications between 1 January 2005 and 30 June 2008 were analysed from the Truven Health MarketScan Commercial and Medicare Supplemental databases. A 12-month baseline period prior to OAB medication initiation was used to classify patients into diabetes and non-diabetes cohorts, and measure demographic and clinical characteristics. Patients in each cohort were directly matched 1 : 1 based on index year, age, gender and geographic region. Multiple logistic regression was used to compare cohorts on outcomes of ≥ 80% adherence to OAB medications and refilling a second OAB medication prescription. Cox's proportional hazards model compared time to non-persistence with OAB medications between both cohorts. RESULTS: In total, 36,560 patients were included in each cohort. Compared with the non-diabetes cohort, the diabetes cohort had 21.5% higher odds of ≥ 80% adherence to OAB medications, 16.6% higher odds of filling a second OAB medication prescription and 10.3% lower hazard of non-persistence with OAB medications during a 12-month evaluation period. CONCLUSIONS: Patients with diabetes were more persistent and adherent to OAB medications and had higher odds of filling a second medication prescription than patients without diabetes. Further research is needed to identify factors responsible for these findings.


Sujet(s)
Complications du diabète/complications , Antagonistes muscariniques/usage thérapeutique , Vessie hyperactive/traitement médicamenteux , Sujet âgé , Femelle , Humains , Mâle , Adhésion au traitement médicamenteux , Études rétrospectives , Facteurs temps , Vessie hyperactive/complications
6.
Acta Physiol (Oxf) ; 203(3): 343-50, 2011 Nov.
Article de Anglais | MEDLINE | ID: mdl-21649862

RÉSUMÉ

AIM: Hypertension is related to abnormalities in autonomic nervous system (ANS) function, with increased sympathetic output and decreased parasympathetic tone. Lifestyle interventions are the first line of treatment in hypertension, and decreased blood pressure (BP) effects may be related to changes in ANS function. Using heart rate recovery (HRR) from exercise as an index of parasympathetic tone and plasma noradrenaline as an index of sympathetic tone, we investigated the effects of lifestyle interventions on ANS function in patients with elevated BP. METHODS: Sedentary participants with elevated BP were randomly assigned to either an exercise only (N = 25), exercise plus dietary approaches to stop hypertension (DASH) diet (N = 12), or waitlist control (N = 15) 12-week intervention. Plasma noradrenaline was measured at rest and participants performed a peak exercise test before and after the intervention. HRR was calculated as peak heart rate (HR) minus HR at 1 min post-exercise. RESULTS: Heart rate recovery showed a significant group by time interaction; both intervention groups showed increases in HRR from pre- to post-intervention, while waitlist showed no change. Similarly, both exercise plus diet and exercise groups, but not waitlist, showed significant reductions in BP from pre- to post-intervention. Linear regression revealed that BP post-intervention was significantly predicted by change in HRR when controlling for pre-BP, age, gender and BMI. CONCLUSIONS: Lifestyle interventions induced training-reduced BP and altered autonomic tone, indexed by HRR. This study indicates the importance of behavioural modification in hypertension and that increased parasympathetic function is associated with success in reduction of BP.


Sujet(s)
Système nerveux autonome/physiopathologie , Pression sanguine , Traitement par les exercices physiques , Hypertension artérielle/thérapie , Comportement de réduction des risques , Adulte , Analyse de variance , Système nerveux autonome/métabolisme , Marqueurs biologiques/sang , Californie , Association thérapeutique , Épreuve d'effort , Femelle , Rythme cardiaque , Humains , Hypertension artérielle/sang , Hypertension artérielle/diétothérapie , Hypertension artérielle/physiopathologie , Modèles linéaires , Mâle , Adulte d'âge moyen , Norépinéphrine/sang , Récupération fonctionnelle , Facteurs temps , Résultat thérapeutique
7.
Microb Ecol ; 56(4): 681-7, 2008 Nov.
Article de Anglais | MEDLINE | ID: mdl-18443847

RÉSUMÉ

Mats of coenocytic "snow molds" are commonly observed covering the soil and litter of alpine and subalpine areas immediately following snow melt. Here, we describe the phylogenetic placement, growth rates, and metabolic potential of cold-adapted fungi from under-snow mats in the subalpine forests of Colorado. SSU rDNA sequencing revealed that these fungi belong to the zygomycete orders Mucorales and Mortierellales. All of the isolates could grow at temperatures observed under the snow at our sites (0 degrees C and -2 degrees C) but were unable to grow at temperatures above 25 degrees C and were unable to grow anaerobically. Growth rates for these fungi were very high at -2 degrees C, approximately an order of magnitude faster than previously studied cold-tolerant fungi from Antarctic soils. Given the rapid aerobic growth of these fungi at low temperatures, we propose that they are uniquely adapted to take advantage of the flush of nutrient that occurs at the soil-snow interface beneath late winter snow packs. In addition, extracellular enzyme production was relatively high for the Mucorales, but quite low for the Mortierellales, perhaps indicating some niche separation between these fungi beneath the late winter snow pack.


Sujet(s)
Écosystème , Champignons/croissance et développement , Phylogenèse , Neige , Arbres/microbiologie , Colorado , Champignons/classification , Champignons/génétique , ARN ribosomique/génétique , Analyse de séquence d'ADN , Température
8.
Cloning Stem Cells ; 5(1): 3-12, 2003.
Article de Anglais | MEDLINE | ID: mdl-12713696

RÉSUMÉ

As the demand for cloned embryos and offspring increases, the need arises for the development of nuclear transfer procedures that are improved in both efficiency and ease of operation. Here, we describe a novel zona-free cloning method that doubles the throughput in cloned bovine embryo production over current procedures and generates viable offspring with the same efficiency. Elements of the procedure include zona-free enucleation without a holding pipette, automated fusion of 5-10 oocyte-donor cell pairs and microdrop in vitro culture. Using this system, zona-free embryos were reconstructed from five independent primary cell lines and cultured either singularly (single-IVC) or as aggregates of three (triple-IVC). Blastocysts of transferable quality were obtained at similar rates from zona-free single-IVC, triple-IVC, and control zona-intact embryos (33%, 25%, and 29%, respectively). In a direct comparison, there was no significant difference in development to live calves at term between single-IVC, triple-IVC, and zona-intact embryos derived from the same adult fibroblast line (10%, 13%, and 15%, respectively). This zona-free cloning method could be straightforward for users of conventional cloning procedures to adopt and may prove a simple, fast, and efficient alternative for nuclear cloning of other species as well.


Sujet(s)
Clonage d'organisme/méthodes , Transfert d'embryon , Zone pellucide/métabolisme , Animaux , Blastocyste/métabolisme , Blastocyste/physiologie , Bovins , Lignée cellulaire , Noyau de la cellule/métabolisme , Embryon de mammifère/physiologie , Femelle , Fécondation in vitro , Fibroblastes/métabolisme , Ovocytes/métabolisme
9.
Science ; 294(5544): 1016-7, 2001 Nov 02.
Article de Anglais | MEDLINE | ID: mdl-11691977

RÉSUMÉ

How does human immunodeficiency virus (HIV) gain access to the carefully guarded nucleus of the host cell? In a Perspective, Segura-Totten and Wilson elaborate on new findings (de Noronha et al.) showing that the HIV protein Vpr is crucial for causing transient herniations in the host cell nuclear envelope. These ruptures are sufficient to enable the preintegration complexes of invading virions to enter the nucleus and to integrate with host cell DNA.


Sujet(s)
Noyau de la cellule/métabolisme , Noyau de la cellule/virologie , Produits du gène vpr/métabolisme , VIH (Virus de l'Immunodéficience Humaine)/physiologie , Enveloppe nucléaire/métabolisme , Intégration virale , Chromatine/métabolisme , Protéines de liaison à l'ADN/métabolisme , Phase G2 , Produits du gène vpr/génétique , Cellules HeLa , Humains , Lamines , Protéines membranaires/métabolisme , Mutation , Enveloppe nucléaire/ultrastructure , Protéines nucléaires/métabolisme , Phosphorylation , Thymopoïétines/métabolisme , Produits du gène vpr du virus de l'immunodéficience humaine
11.
EMBO J ; 20(16): 4399-407, 2001 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-11500367

RÉSUMÉ

The nuclear envelope proteins LAP2, emerin and MAN1 share a conserved approximately 40-residue 'LEM' motif. Loss of emerin causes Emery-Dreifuss muscular dystrophy. We have solved the solution NMR structure of the constant region of human LAP2 (residues 1-168). Human LAP2(1-168) has two structurally independent, non-interacting domains located at residues 1-50 ('LAP2-N') and residues 111-152 (LEM-domain), connected by an approximately 60-residue flexible linker. The two domains are structurally homologous, comprising a helical turn followed by two helices connected by an 11-12-residue loop. This motif is shared by subdomains of T4 endonuclease VII and transcription factor rho, despite negligible (< or =15%) sequence identity. NMR chemical shift mapping demonstrated that the LEM-domain binds BAF (barrier-to-autointegration factor), whereas LAP2-N binds DNA. Both binding surfaces comprise helix 1, the N-terminus of helix 2 and the inter-helical loop. Binding selectivity is determined by the nature of the surface residues in these binding sites, which are predominantly positively charged for LAP2-N and hydrophobic for the LEM-domain. Thus, LEM and LEM-like motifs form a common structure that evolution has customized for binding to BAF or DNA.


Sujet(s)
Protéines de liaison à l'ADN/composition chimique , Protéines de liaison à l'ADN/métabolisme , ADN/métabolisme , Protéines membranaires/composition chimique , Protéines nucléaires , Séquence d'acides aminés , ADN/composition chimique , Humains , Protéines membranaires/métabolisme , Modèles moléculaires , Données de séquences moléculaires , Enveloppe nucléaire/métabolisme , Nucléoprotéines/métabolisme , Structure tertiaire des protéines , Solutions
13.
EMBO J ; 20(7): 1754-64, 2001 Apr 02.
Article de Anglais | MEDLINE | ID: mdl-11285238

RÉSUMÉ

LAP2 belongs to a family of nuclear membrane proteins sharing a 43 residue LEM domain. All LAP2 isoforms have the same N-terminal 'constant' region (LAP2-c), which includes the LEM domain, plus a C-terminal 'variable' region. LAP2-c polypeptide inhibits nuclear assembly in Xenopus extracts, and binds in vitro to barrier-to-autointegration factor (BAF), a DNA-bridging protein. We tested 17 Xenopus LAP2-c mutants for nuclear assembly inhibition, and binding to BAF and BAF small middle dotDNA complexes. LEM domain mutations disrupted all activities tested. Some mutations outside the LEM domain had no effect on binding to BAF, but disrupted activity in Xenopus extracts, suggesting that LAP2-c has an additional unknown function required to inhibit nuclear assembly. Mutagenesis results suggest that BAF changes conformation when complexed with DNA. The binding affinity of LAP2 was higher for BAF small middle dotDNA complexes than for BAF, suggesting that these interactions are physiologically relevant. Nucleoplasmic domains of Xenopus LAP2 isoforms varied 9-fold in their affinities for BAF, but all isoforms supershifted BAF small middle dotDNA complexes. We propose that the LEM domain is a core BAF-binding domain that can be modulated by the variable regions of LAP2 isoforms.


Sujet(s)
Protéines de liaison à l'ADN/métabolisme , ADN/métabolisme , Protéines membranaires/métabolisme , Protéines nucléaires/métabolisme , Séquence d'acides aminés , Animaux , Sites de fixation , Noyau de la cellule/physiologie , Protéines de liaison à l'ADN/composition chimique , Protéines membranaires/génétique , Données de séquences moléculaires , Mutagenèse , Protéines nucléaires/génétique , Conformation des protéines , Isoformes de protéines/génétique , Isoformes de protéines/métabolisme , Solutions , Xenopus laevis
15.
Histol Histopathol ; 16(1): 1-14, 2001 01.
Article de Anglais | MEDLINE | ID: mdl-11193183

RÉSUMÉ

Papillary thyroid carcinomas (PTCs) have characteristic nuclear shape changes compared to follicular-type thyroid epithelium. We tested the hypothesis that the altered nuclear shape results from altered distribution or expression of the major structural proteins of the nuclear envelope. Lamin A, lamin B1, lamin C, lamin B receptor (LBR), lamina-associated polypeptide 2 (LAP2), emerin, and nuclear pores were examined. PTC's with typical nuclear features by H&E were compared to non-neoplastic thyroid and follicular neoplasms using confocal microscopy, and semi-quantitative immunoblotting. Lamin A/C, lamin B1, LAP2, emerin, and nuclear pores all extend throughout the grooves and intranuclear inclusions of PTC. Their distribution and fluorescent intensity is not predictably altered relative to nuclear envelope irregularities. By immunoblotting, the abundance (per cell) and electrophoretic mobilities of lamin A, lamin B1, lamin C, emerin, and LAP2 proteins do not distinguish PTC, normal thyroid, or follicular neoplasms. These results do not support previously published predictions that lamin A/C expression is related to a loss of proliferative activity. At least three LAP2 isoforms are identified in normal and neoplastic thyroid. LBR is sparse or undetectable in all the thyroid samples. The results suggest that the irregular nuclear shape of PTC is not determined by these nuclear envelope structural proteins per se. We review the structure of the nuclear envelope, the major factors that determine nuclear shape, and the possible functional consequences of its alteration in PTC.


Sujet(s)
Carcinome papillaire folliculaire/ultrastructure , Enveloppe nucléaire/ultrastructure , Tumeurs de la thyroïde/ultrastructure , Technique de Western , Fractionnement cellulaire , Centrifugation en gradient de densité , Électrophorèse , Technique d'immunofluorescence directe , Humains , Isomérie , Laminine/immunologie , Laminine/métabolisme , Laminine/ultrastructure , Protéines membranaires/immunologie , Protéines membranaires/métabolisme , Protéines membranaires/ultrastructure , Microscopie confocale , Protéines nucléaires/métabolisme , Protéines nucléaires/ultrastructure , Thymopoïétines/immunologie , Thymopoïétines/métabolisme , Fixation tissulaire
16.
Trends Biochem Sci ; 26(1): 41-7, 2001 Jan.
Article de Anglais | MEDLINE | ID: mdl-11165516

RÉSUMÉ

The number and complexity of genes encoding nuclear lamina proteins has increased during metazoan evolution. Emerging evidence reveals that transcriptional repressors such as the retinoblastoma protein, and apoptotic regulators such as CED-4, have functional and dynamic interactions with the lamina. The discovery that mutations in nuclear lamina proteins cause heritable tissue-specific diseases, including Emery-Dreifuss muscular dystrophy, is prompting a fresh look at the nuclear lamina to devise models that can account for its diverse functions and dynamics, and to understand its enigmatic structure.


Sujet(s)
Apoptose/génétique , Structures nucléaires , Évolution moléculaire , Protéines nucléaires/physiologie , Transcription génétique , Animaux , Structures nucléaires/génétique , Structures nucléaires/métabolisme , Eucaryotes/physiologie , Régulation de l'expression des gènes , Maladies génétiques congénitales/génétique , Maladies génétiques congénitales/métabolisme , Hétérochromatine/métabolisme , Humains , Membranes intracellulaires/métabolisme , Lamines , Dystrophie musculaire d'Emery-Dreifuss/génétique
17.
Cell Mol Life Sci ; 58(12-13): 1737-40, 2001 Nov.
Article de Anglais | MEDLINE | ID: mdl-11766874

RÉSUMÉ

The chromosomes of eukaryotic cells are separated from the cytoplasm by the nuclear envelope. The nuclear envelope includes two riveted membranes, plus embedded pore complexes that mediate nuclear import and export. In this sense, the nuclear envelope is truly a border zone. However, the envelope also links directly to chromosomes, and anchors two major infrastructures--the nuclear lamina and Tpr filaments--to the nuclear perimeter. Proteins of the nuclear envelope mediate a variety of fundamental activities, including DNA replication, gene expression and silencing, chromatin organization, cell division, apoptosis, sperm nuclear remodeling, the behavior of pronuclei, cell fate determination, nuclear migration and cell polarity. Furthermore, mutations in nuclear lamins and lamin-binding proteins cause tissue-specific inherited diseases. This special issue of Cell and Molecular Life Sciences is devoted to recent major advances in the characterization of nuclear envelope proteins and their roles. We offer here an overview of the topics covered in this issue of CMLS, and also discuss the emerging recognition that the nuclear envelope is an organelle critical for a wide range of genetic and developmental activity in multicellular organisms.


Sujet(s)
Noyau de la cellule/métabolisme , Enveloppe nucléaire/physiologie , Protéines nucléaires/métabolisme , Animaux , Cycle cellulaire/physiologie , Humains , Lamines , Dystrophies musculaires/physiopathologie , Enveloppe nucléaire/composition chimique , Protéines nucléaires/génétique , Protéine G ran/métabolisme
18.
J Cell Sci ; 114(Pt 24): 4567-73, 2001 Dec.
Article de Anglais | MEDLINE | ID: mdl-11792821

RÉSUMÉ

Loss of emerin, a lamin-binding nuclear membrane protein, causes Emery-Dreifuss muscular dystrophy. We analyzed 13 site-directed mutations, and four disease-causing mutations that do not disrupt emerin stability or localization. We show that emerin binds directly to barrier-to-autointegration factor (BAF), a DNA-bridging protein, and that this binding to BAF requires conserved residues in the LEM-motif of emerin. Emerin has two distinct functional domains: the LEM-domain at the N-terminus, which mediates binding to BAF, and a second functional domain in the central region, which mediates binding to lamin A. Disease mutation Delta95-99 mapped to the lamin-binding domain and disrupted lamin A binding in vitro. Two other disease-linked residues, Ser54 and Pro183, mapped outside the BAF and lamin-binding domains, suggesting that emerin may have additional functional domains relevant to disease. The disease-linked emerin proteins all remained active for binding to BAF, both in vitro and in vivo, suggesting that disease can result from the loss of specific molecular interactions between emerin and either lamin A or putative novel partner(s). The demonstration that emerin binds directly to BAF, coupled to similar results for LAP2, provides proof in principle that all LEM-domain nuclear proteins can interact with BAF, with interesting implications for chromatin attachment to the nuclear envelope.


Sujet(s)
Protéines de liaison à l'ADN/métabolisme , Protéines membranaires/métabolisme , Dystrophie musculaire d'Emery-Dreifuss/métabolisme , Protéines nucléaires/métabolisme , Thymopoïétines/métabolisme , Séquence d'acides aminés , Protéines de liaison à l'ADN/génétique , Délétion de gène , Cellules HeLa , Humains , Lamine A , Lamines , Protéines membranaires/génétique , Protéines membranaires/physiologie , Données de séquences moléculaires , Dystrophie musculaire d'Emery-Dreifuss/génétique , Mutagenèse dirigée , Mutation ponctuelle , Liaison aux protéines/génétique , Structure tertiaire des protéines/génétique , Protéines recombinantes/métabolisme , Thymopoïétines/génétique , Thymopoïétines/physiologie
19.
J Cell Sci ; 114(Pt 24): 4575-85, 2001 Dec.
Article de Anglais | MEDLINE | ID: mdl-11792822

RÉSUMÉ

Mutations in emerin cause the X-linked recessive form of Emery-Dreifuss muscular dystrophy (EDMD). Emerin localizes at the inner membrane of the nuclear envelope (NE) during interphase, and diffuses into the ER when the NE disassembles during mitosis. We analyzed the recruitment of wildtype and mutant GFP-tagged emerin proteins during nuclear envelope assembly in living HeLa cells. During telophase, emerin accumulates briefly at the 'core' region of telophase chromosomes, and later distributes over the entire nuclear rim. Barrier-to-autointegration factor (BAF), a protein that binds nonspecifically to double-stranded DNA in vitro, co-localized with emerin at the 'core' region of chromosomes during telophase. An emerin mutant defective for binding to BAF in vitro failed to localize at the 'core' in vivo, and subsequently failed to localize at the reformed NE. In HeLa cells that expressed BAF mutant G25E, which did not show 'core' localization, the endogenous emerin proteins failed to localize at the 'core' region during telophase, and did not assemble into the NE during the subsequent interphase. BAF mutant G25E also dominantly dislocalized LAP2beta and lamin A from the NE, but had no effect on the localization of lamin B. We conclude that BAF is required for the assembly of emerin and A-type lamins at the reforming NE during telophase, and may mediate their stability in the subsequent interphase.


Sujet(s)
Protéines de liaison à l'ADN/physiologie , Protéines membranaires/métabolisme , Enveloppe nucléaire/métabolisme , Thymopoïétines/métabolisme , Séquence d'acides aminés , Protéines de liaison à l'ADN/génétique , Protéines de liaison à l'ADN/métabolisme , Cellules HeLa , Humains , Lamine A , Lamine B , Lamines , Protéines membranaires/génétique , Données de séquences moléculaires , Mutagenèse dirigée , Mutation faux-sens , Protéines nucléaires/génétique , Protéines nucléaires/métabolisme , Structure tertiaire des protéines/génétique , Délétion de séquence , Télophase/génétique , Thymopoïétines/génétique
20.
Mol Biol Cell ; 11(9): 3089-99, 2000 Sep.
Article de Anglais | MEDLINE | ID: mdl-10982402

RÉSUMÉ

Emerin, MAN1, and LAP2 are integral membrane proteins of the vertebrate nuclear envelope. They share a 43-residue N-terminal motif termed the LEM domain. We found three putative LEM domain genes in Caenorhabditis elegans, designated emr-1, lem-2, and lem-3. We analyzed emr-l, which encodes Ce-emerin, and lem-2, which encodes Ce-MAN1. Ce-emerin and Ce-MAN1 migrate on SDS-PAGE as 17- and 52-kDa proteins, respectively. Based on their biochemical extraction properties and immunolocalization, both Ce-emerin and Ce-MAN1 are integral membrane proteins localized at the nuclear envelope. We used antibodies against Ce-MAN1, Ce-emerin, nucleoporins, and Ce-lamin to determine the timing of nuclear envelope breakdown during mitosis in C. elegans. The C. elegans nuclear envelope disassembles very late compared with vertebrates and Drosophila. The nuclear membranes remained intact everywhere except near spindle poles during metaphase and early anaphase, fully disassembling only during mid-late anaphase. Disassembly of pore complexes, and to a lesser extent the lamina, depended on embryo age: pore complexes were absent during metaphase in >30-cell embryos but existed until anaphase in 2- to 24-cell embryos. Intranuclear mRNA splicing factors disassembled after prophase. The timing of nuclear disassembly in C. elegans is novel and may reflect its evolutionary position between unicellular and more complex eukaryotes.


Sujet(s)
Protéines de Caenorhabditis elegans , Caenorhabditis elegans/génétique , Cycle cellulaire/physiologie , Protéines membranaires/métabolisme , Enveloppe nucléaire/ultrastructure , Pore nucléaire/physiologie , Protéines nucléaires/métabolisme , Thymopoïétines/métabolisme , Séquence d'acides aminés , Animaux , Caenorhabditis elegans/cytologie , Caenorhabditis elegans/physiologie , Protéines de liaison à l'ADN , Embryon non mammalien/physiologie , Humains , Lamines , Protéines membranaires/composition chimique , Protéines membranaires/génétique , Métaphase , Mitose/physiologie , Données de séquences moléculaires , Pore nucléaire/ultrastructure , Protéines nucléaires/composition chimique , Protéines nucléaires/génétique , Alignement de séquences , Similitude de séquences d'acides aminés , Thymopoïétines/composition chimique , Thymopoïétines/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE